Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|April 25, 2007
The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based studySverker Hasselblom, Börje Ridell, Herman Nilsson-Ehle, et al.
Leukemia & Lymphoma|December 16, 2006
Evaluation of clinical staging in chronic lymphocytic leukemia- population-based studyPeter Apelgren, Sverker Hasselblom, Olle Werlenius, et al.
Acta Oncologica (Stockholm, Sweden)|March 15, 2005
Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical studySverker Hasselblom, Börje Ridell, Hans Wedel, et al.
British Journal of Haematology|April 26, 2007
The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphomaSverker Hasselblom, Margret Sigurdadottir, Ulrika Hansson, et al.
Leukemia & Lymphoma|September 4, 2008
Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphomaSverker Hasselblom, Borje Ridell, Margret Sigurdardottir, et al.
Annals of Hematology|October 18, 2006
The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL)Katarina Junevik, Olle Werlenius, Sverker Hasselblom, et al.
Pathology International|August 19, 2008
Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosisSverker Hasselblom, Ulrika Hansson, Margret Sigurdardottir, et al.
Leukemia & Lymphoma|June 18, 2020
TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphomaSusanne Bram Ednersson, Mimmie Stern, Henrik Fagman, et al.
International Journal of Proteomics|June 11, 2015
SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma PatientsUlla Rüetschi, Martin Stenson, Sverker Hasselblom, et al.
British Journal of Haematology|March 6, 2010
High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapySverker Hasselblom, Ulrika Hansson, Markus Olsson, et al.
Pageof 2